On October 22, the Kechuang 100 ETF Fund (588220) closed down 1.21%, with a turnover of 732 million yuan.
The STAR 100 ETF Fund (588220) was established on September 6, 2023, and the full name of the fund is Penghua SSE STAR Market 100 ETF ETF Fund, and the fund is referred to as the STAR 100 ETF Fund. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the STAR 100 ETF Fund (588220) is based on the return rate of the SSE STAR Market 100 Index.
In terms of scale, as of October 21, the latest share of the Science and Technology Innovation 100 ETF Fund (588220) was 8.801 billion shares, and the latest scale was 8.006 billion yuan. Looking back on December 29, 2023, the share of the Science and Technology Innovation 100 ETF Fund (588220) was 7.894 billion shares, and the scale was 7.702 billion yuan. That is, the share of the fund has increased by 11.48% and the scale has increased by 3.94% since the beginning of this year.
In terms of liquidity, as of October 22, the cumulative turnover of the Kechuang 100 ETF Fund (588220) in the past 20 trading days was 15.204 billion yuan, with an average daily turnover of 760 million yuan, and since the beginning of this year, the cumulative turnover in 192 trading days has been 115.450 billion yuan, with an average daily turnover of 601 million yuan.
The current fund manager of the STAR 100 ETF Fund (588220) is Su Junjie. Su Junjie has managed (or intends to manage) the fund since September 6, 2023, with a return of -9.03% during his tenure.
According to the latest regular report, the heavy stocks of the Science and Technology Innovation 100 ETF Fund (588220) include Huitai Medical, Nine Company, Allist, BeiGene, Smartway, Anji Technology, Hengxuan Technology, Borui Pharmaceutical, NOVOSENSE, and Zhuhai Guanyu, and the proportion of holdings is as follows.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 688617 | Huitai Medical | 3.74% | 393,00179 | million |
| 689009 | No. 9 Company | 3.23% | 4,208,3015 | million |
| 688578 | Allist | , 2.51%, | 1,890,900,121 | million |
| 688235 | BeiGene | , 2.33%, | 966,3012 | million |
| 688213 | Smartway | 2.04%, | 2,018,0097,873,400 | |
| 688019 | Anji Technology | 1.99%, | 757,209,555,540 | |
| 688608 | Hengxuan Technology | 1.84%, | 604,308,451,300 | |
| 688166 | Borui | Pharmaceutical1.81%, | 2,484,786,964,400 | |
| 688052 | NOVOSENSE | 1.80%, | 840,486,377,400 | |
| 688772 | Zhuhai Guanyu | 1.77%, | 5,688,208,754,200 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
